Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG0568

NPHP1 Knockout MDCK Cell Line

  • Product Type:

    Genome-edited Cells

  • Tissue Source:

    Kidney

  • Gene Species:

    Canis lupus familiaris (Dog)

The NPHP1 Knockout MDCK Cell Line is a CRISPR/Cas9-edited canine kidney epithelial model with targeted disruption of NPHP1, which encodes nephrocystin-1??a ciliary transition zone protein that functions in a complex with NPHP4 and INVS. Derived from MDCK cells, this line offers a polarized epithelial system for investigating ciliopathy mechanisms. Nephrocystin-1 loss impairs primary cilium formation and disrupts Wnt/??-catenin and Shh/Gli signaling, affecting downstream ??-catenin transcriptional targets and Gli transcription factors. This model supports renal disease research, epithelial barrier studies, and drug screening for nephronophthisis and related syndromes.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    MDCK

    Age

    Adult

    Sex of Donor

    Female

    Gene Name

    NPHP1

    Gene Alias

    nephrocystin 1; NPH1

    Gene Species

    Canis lupus familiaris (Dog)

    Gene Identifier

    NCBI Gene ID 403780

    Gene Family

    Ciliary SH3-domain protein family

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

    Pathogens

    Cells tested negative for HIV-1, HBV, and HCV.

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The NPHP1 Knockout MDCK Cell Line is a genetically modified canine kidney epithelial cell product in which the NPHP1 gene has been disrupted using CRISPR/Cas9-mediated genome editing. This knockout model provides a stable loss-of-function platform for investigating the cellular and molecular consequences of nephrocystin-1 deficiency. The parental MDCK (Madin-Darby Canine Kidney) cell line is a widely used, non-tumorigenic epithelial model derived from normal canine kidney. MDCK cells form highly polarized monolayers with tight junctions and exhibit vectorial ion transport, making them ideal for studying epithelial barrier function and cell polarity. The cells maintain ciliogenesis capability under appropriate culture conditions, providing a relevant context for examining ciliary protein function. NPHP1 encodes nephrocystin-1, a critical component of the ciliary transition zone that functions as a gatekeeper for protein entry and exit from the primary cilium. Within the transition zone, nephrocystin-1 forms complexes with NPHP4, INVS, and RPGRIP1L, and directly interacts with ??-catenin and P-cadherin to coordinate ciliary signaling with cell?Ccell adhesion. It operates downstream of HNF1B and is activated by Wnt and Shh ligands, while mediating signaling to downstream effectors including ??-catenin-driven transcriptional programs, Gli transcription factors, and RhoA-dependent cytoskeletal remodeling. Consequently, NPHP1 integrates ciliary gate regulation with key developmental pathways such as Wnt/??-catenin and Sonic hedgehog cascades. Disruption of NPHP1 in MDCK cells impairs primary cilium formation and compromises the establishment of polarized epithelial architecture. Without functional nephrocystin-1, the transition zone loses its selective barrier, leading to aberrant ciliary trafficking, diminished hedgehog signaling, and destabilized junctional complexes. These defects are manifest as altered ??-catenin distribution, reduced transepithelial electrical resistance, and disorganized actin cytoskeleton ?C features that recapitulate aspects of renal ciliopathy phenotypes. Thus, this knockout cell line serves as a powerful in vitro surrogate for studying nephronophthisis type 1 and related syndromes in a kidney epithelial setting. Researchers can employ this knockout line to dissect ciliary signaling mechanisms using immunofluorescence for ciliary markers such as acetylated ??-tubulin or Arl13b, and to quantify barrier integrity via transepithelial electrical resistance measurements. It is well suited for drug testing screens targeting nephronophthisis, functional analysis of Wnt/Shh crosstalk through RT-qPCR of target genes such as AXIN2 and GLI1, and co-immunoprecipitation studies to map nephrocystin-1 interaction networks. Additional applications include evaluating wound healing dynamics, assessing ??-catenin localization by flow cytometry, and investigating the role of NPHP1 in polarity establishment. For further details or custom inquiries, please contact Ascent Research.
Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)